Effectiveness of aprepitant in post-acute COVID19 syndrome.

Rocio Reinoso-Arija Cecilia Lopez Ramirez José Antonio Jimenez-Ruiz José Luis López-Campos

Published in: Clinical case reports (2021)

This is the first case of a patient taking aprepitant for a post-acute COVID-19 syndrome. This case may encourage researchers to look for the evidence for the efficacy and safety of a neurokinin 1 receptor antagonist in this frequent syndrome.

Keyphrases

case report
coronavirus disease
sars cov
liver failure
respiratory failure
systematic review
drug induced
aortic dissection
respiratory syndrome coronavirus
mechanical ventilation